Céline Clemenson

Title: Céline Clemenson: Innovator in Freeze-Dried Formulations

Introduction

Céline Clemenson is a notable inventor based in Orsay, France. He has made significant contributions to the field of pharmaceutical formulations, particularly in the preparation of freeze-dried compounds. His innovative work has led to the development of a unique process that enhances the stability and efficacy of certain chemical formulations.

Latest Patents

Céline Clemenson holds 1 patent for his invention titled "Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino]ethanethiol formulation." This patent describes a method that includes the reaction of a solution of amifostine with a strong acid to obtain a solution of 2-[(3-aminopropyl)amino]ethanethiol, followed by the freeze-drying of this solution, with or without the addition of excipients. This process is crucial for creating stable pharmaceutical products that can be stored for extended periods.

Career Highlights

Throughout his career, Céline has worked with prominent organizations in the pharmaceutical industry. Notably, he has been associated with Clevexel Pharma, where he contributed to the development of innovative drug formulations. Additionally, he has worked at the Institut Gustave Roussy, a leading cancer research center, further enhancing his expertise in pharmaceutical sciences.

Collaborations

Céline has collaborated with several professionals in his field, including Xiuping Wang-Zhang and Perrine Pivette. These collaborations have allowed him to expand his research and contribute to various projects aimed at improving drug delivery systems.

Conclusion

Céline Clemenson's work in the preparation of freeze-dried formulations represents a significant advancement in pharmaceutical technology. His innovative processes and collaborations with esteemed colleagues highlight his commitment to improving drug stability and efficacy.